Suzhou Hanerxi Medical Device Development Co., Ltd, a specialist in pen syringe technology based in Suzhou, has reportedly secured “hundreds of millions” of renminbi in a Series B financing round. The round was led by Fuzhe Equity Investment Fund and Jiangsu Trautec Medical Technology Co., Ltd., with additional contributions from And Rui Venture Capital and other investors. The funds raised will be directed towards the construction of what is set to become Asia’s largest facility for the production of injection pens and administration devices.-Fineline Info & Tech
Recent news:
-
Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement -
Abbott Laboratories' Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment -
Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy -
Genmab's Tivdak Approved in Japan for Advanced Cervical Cancer Treatment -
CStone Pharmaceuticals Reports 2024 Results with License Fee Growth Offsetting Drug Sales Decline
